Immunohistochemistry identified high expression of HNF1B and low expression of low estrogen receptor alpha (ERa) in ovarian CCC, whereas high expression of ERa and low expression of HNF1B were observed in endometrioid carcinoma [30,31]. This evidence concerns the gene HNF1B and endometrioid adenocarcinoma.